Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2012-07-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyperglycemia as a Prognostic Factor In Acute Ischemic Stroke Patients
NCT04196322
Normoglycemia and Neurological Outcome
NCT01137773
Stress Hyperglycemia and Acute Ischemic Stroke
NCT04408768
Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy
NCT00505505
Procoagulant Effects of Hyperglycemia After Acute Stroke: A Pilot Study
NCT00373269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this patient registry admission HbA1c within 72 hours after confirmed aneurysmal subarachnoid hemorrhage in patients aged over 18 years is determined and correlated with clinical course and neurological outcome after 6 month as determined by modified Rankin score. Additionally, patients are monitored for incidence of delayed cerebral ischemia (DCI) and the incidence of new infarction on the discharge ct scan attributable to DCI. General treatment of cerebral aneurysm and subarachnoid hemorrhage in all patients follows international guidelines.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
aneurysmal subarachnoid hemorrhage
observational, no intervention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admission within 72hours after hemorrhage
* Age \>18 years
Exclusion Criteria
* admission \>72hours after hemorrhage
* Age \<18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heinrich-Heine University, Duesseldorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kerim Beseoglu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Neurosurgery, Heinrich-Heine-University, Düsseldorf
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurosurgery, Heinrich-Heine-University Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UKD-NCH-2014-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.